Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Document:CIOMS CIOMS - International Ethical Guidelines for Health-related Research Involving Humans 2016  + (Current)
• Document:ICH ICH E11 Guideline R1 (2017)  + (Current)
• Document:ICH ICH E19 Guideline 2022  + (Current)
• Document:ICH ICH E2A Guideline 1994  + (Current)
• Document:ICH ICH E2F Guideline 2010  + (Current)
• Document:ICH ICH E3 Guideline 1995  + (Current)
• Document:ICH ICH E6 Guideline R3 (2025)  + (Current)
• Document:ICH ICH E7 Guideline 1993  + (Current)
• Document:ICH ICH E8 Guideline R1 (2021)  + (Current)
• Document:ICH ICH E9 Guideline - Addendum R1 20-Nov-2019  + (Current)
• Document:ICH ICH E9 Guideline 1998  + (Current)
• Document:INT ISPE - GPP Revision 3 (2015)  + (Current)
• Document:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020  + (Current)
• Document:WHO WHO - Guidance for best practices for clinical trials 2024  + (Current)
• Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995  + (Current)
• Document:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005  + (Current)
• Document:WHO WHO - ICD 11  + (Current)
• Document:WMA Declaration of Helsinki 2024  + (Current)
• Document:DEU Deutsches Ärzteblatt 45849  + (Current)
• Document:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838  + (Current)
• Document:WHO WHO Good Practices for Clinical Trial Design and Implementation 04-May-2026  + (Current)
• Document:N.A. Minimum Criteria for ICH E6 (R3) GCP Investigator Site Personnel Training V3.0  + (Current)
• Document:N.A. Transcelerate GCP mutual recognition programm FAQ 21-May-2025  + (Current)
• Document:GBR MHRA GCP Inspection Dossier template V7.0  + (Current)
• Document:SMW Test  + (Current)
• Document:DEU Richtlinie zur Bewertung der Qualifikation von Prüfern, Hauptprüfern, Leitern und ärztlichen Mitgliedern von Prüfungsteams durch Ethik-Kommissionen von Arbeitskreis Medizinischer Ethik-Kommissionen in der Bundesrepublik Deutschland e. V. und  + (Current)

• Document:ICH ICH E6 Guideline - Annex 2 R3 Annex 2  + (Draft)

• Document:AUT Question - BASG 11-Feb-2025  + (N.A.)
• Document:EU CHMP Guidelines -  + (N.A.)
• Document:EU EMA Guidelines -  + (N.A.)
• Document:EU Eudralex - volume 4 GMP Guidelines Annex 11 Jan-2011  + (N.A.)
• Document:EU Eudralex - volume 4 GMP Guidelines Chapter 4 Jan-2011  + (N.A.)
• Document:EU MDCG Guidelines -  + (N.A.)
• Document:EU Regulation (EU) 2017/745 - Medical Device Regulation 05-May-2017 Preamble  + (N.A.)
• Document:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 05-May-2017 Preamble  + (N.A.)
• Document:EU Regulation (EU) 536/2014 - clinical trials 27-May-2014 Preamble  + (N.A.)
• Document:CIOMS CIOMS Publications -  + (N.A.)
• Document:ICH ICH E21 Concept paper 2023  + (N.A.)
• Document:ICH ICH Guidelines -  + (N.A.)
• Document:IMDRF IMDRF – Guidelines -  + (N.A.)
• Document:INT Nuremberg Code 1947  + (N.A.)
• Document:N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008  + (N.A.)
• Document:N.A. Article from Mora et al. 2023  + (N.A.)
• Document:N.A. SPIRIT 2013 - Chan et al. 2013  + (N.A.)
• Document:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report  + (N.A.)
• Document:WHO World Health Organization -  + (N.A.)
• Document:USA WARNING LETTER - Purolea Cosmetics Lab MARCS-CMS 722591 46114  + (N.A.)
• Document:AUT BASG - FAQ 11-Feb-2025  + (Superseded / Invalid)
• Document:AUT FAQ - COVID-19 Studien 15-Mar-2021  + (Superseded / Invalid)
• Document:USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3  + (Superseded / Invalid)
• Document:USA FDA Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs — Improving Human Subject Protection Jan-2009  + (Superseded / Invalid)
• Document:USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020  + (Superseded / Invalid)